|
⚲
|
| Keyboard |
| Crestovo Investor LLC
✚
|
|
|---|---|
| CIK # | 0001849829 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001849829] | |
| 4 | [0001849829] | |
| SC 13D | [0001849829] |
| Form 13D/13G Filer | Form 13D/13G Subject | Filed |
|---|---|---|
| Crestovo Investor LLC | Finch Therapeutics Group Inc | [2021-04-01] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Finch Therapeutics Group Inc | |
| Crestovo Investor LLC | |
| Shumway Chris |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Finch Therapeutics Group Inc FNCH
Common Stock
|
2021-03-23 | Conversion | 11,906,147 | ||
|
Finch Therapeutics Group Inc FNCH
Common Stock
|
2021-03-23 | Buy | 735,294 | $17.00 | 12,499,998 |
|
Finch Therapeutics Group Inc FNCH
Series B Preferred Stock · derivative
|
2021-03-23 | Conversion | 1,064,466 | ||
|
Finch Therapeutics Group Inc FNCH
Series C Preferred Stock · derivative
|
2021-03-23 | Conversion | 1,172,480 | ||
|
Finch Therapeutics Group Inc FNCH
Series A Preferred Stock · derivative
|
2021-03-23 | Conversion | 8,672,117 | ||
|
Finch Therapeutics Group Inc FNCH
Series D Preferred Stock · derivative
|
2021-03-23 | Conversion | 997,084 |